Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study

CONTEXT: Combining a sodium-glucose cotransporter 2 inhibitor with a xanthine oxidase inhibitor (XOI) and a urate transporter 1 (URAT1) inhibitor may enhance serum uric acid (sUA) lowering. However, concerns exist regarding high urinary UA (uUA) excretion rates and subsequent crystallization in rena...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Endocrinol Metab
Hlavní autoři: Stack, Austin G, Han, David, Goldwater, Ronald, Johansson, Susanne, Dronamraju, Nalina, Oscarsson, Jan, Johnsson, Eva, Parkinson, Joanna, Erlandsson, Fredrik
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Clinical Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063233/
https://ncbi.nlm.nih.gov/pubmed/33075806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa748
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky